D. E. Shaw & Co., Inc.

Position in ABEO — Abeona Therapeutics Inc.

CIK 1009207 New York, NY

Position in ABEO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$352,878

-$99,893 QoQ

Shares Held

57,100

-43.5% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 125 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. ABEO ranks #186 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$352,878	57,100	-43.5%	Shares	Defined	2026-08-14
2026-03-31	$452,771	101,065	-4.6%	Shares	Defined	2026-05-15
2025-12-31	$558,435	105,965	-16.2%	Shares	Defined	2026-02-17
2025-09-30	$667,307	126,384	-89.7%	Shares	Defined	2025-11-14
2022-06-30	$258,406	1,230,507	-39.5%	Shares	Defined	2022-08-15
2022-03-31	$650,928	2,034,151	-19.2%	Shares	Defined	2022-05-16
2021-12-31	$856,342	2,518,655	+2924.6%	Shares	Defined	2022-02-14
2020-12-31	$130,737	83,272	-60.2%	Shares	Defined	2021-02-16
2020-09-30	$213,531	209,345	+12.8%	Shares	Defined	2020-11-16
2020-06-30	$542,007	185,619	-19.2%	Shares	Defined	2020-08-14
2020-03-31	$482,718	229,866	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.